Michael I. Greenebaum
President at Greenebaum & Rose Associates, Inc.
Profile
Michael I.
Greenebaum is currently a Director at Profectus BioSciences, Inc., the University of Maryland School of Medicine, the Greenebaum Family Foundation, and the University of Maryland Marlene & Stewart Greenebaum Cancer.
He is also the President of Greenebaum & Rose Associates, Inc. and a Trustee at McDonogh School.
Previously, he was a Director at WellDoc, Inc.
Michael I. Greenebaum active positions
| Companies | Position | Start |
|---|---|---|
Greenebaum & Rose Associates, Inc.
 Greenebaum & Rose Associates, Inc. Real Estate DevelopmentFinance Greenebaum & Rose Associates, Inc. engages in a real estate industry. The company was founded by Stewart Greenebaum and Samuel Rose in 1981 and is headquartered in Baltimore, MD. | President | - |
| Greenebaum Family Foundation | Director/Board Member | - |
| McDonogh School | Director/Board Member | - |
Profectus BioSciences, Inc.
 Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | Director/Board Member | - |
| University of Maryland School of Medicine | Director/Board Member | - |
| University of Maryland Marlene & Stewart Greenebaum Cancer | Director/Board Member | - |
Former positions of Michael I. Greenebaum
| Companies | Position | End |
|---|---|---|
WellDoc, Inc.
 WellDoc, Inc. Packaged SoftwareTechnology Services WellDoc, Inc. develops technology solutions to support chronic disease management. Its product DiabetesManager provides a system for patients and health care providers to coordinate diabetes care, propel self-management and achieve long-term adherence. The company was founded by Ryan Sysko, Yves Nordmann and Suzanne Sysko Clough in 2005 and is headquartered in Columbia, MD. | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
WellDoc, Inc.
WellDoc, Inc. Packaged SoftwareTechnology Services WellDoc, Inc. develops technology solutions to support chronic disease management. Its product DiabetesManager provides a system for patients and health care providers to coordinate diabetes care, propel self-management and achieve long-term adherence. The company was founded by Ryan Sysko, Yves Nordmann and Suzanne Sysko Clough in 2005 and is headquartered in Columbia, MD. | Technology Services |
Greenebaum & Rose Associates, Inc.
Greenebaum & Rose Associates, Inc. Real Estate DevelopmentFinance Greenebaum & Rose Associates, Inc. engages in a real estate industry. The company was founded by Stewart Greenebaum and Samuel Rose in 1981 and is headquartered in Baltimore, MD. | Finance |
| Greenebaum Family Foundation | |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | Health Technology |
| University of Maryland Marlene & Stewart Greenebaum Cancer |
- Stock Market
- Insiders
- Michael I. Greenebaum
